2021 Fall Forum: Depression Across the Lifespan

On

Featuring:

Alan F. Schatzberg, MD
and
Gabriela Livas Stein, PhD
and
Namkee Choi, PhD
and
Shawn Jones, PhD, MHS
and
Gabrielle Liverant, PhD
and
David Mischoulon, MD, PhD
and
Professional
2021 Fall Forum: Depression Across the Lifespan
Thursday, October 21, 2021 11:00 am
- 2:00 pm ET
Level
Introductory
Intermediate
Category
Depression
Pharmacology
Treatment
CE/CME Credit
3.00

Member Prices

60.00

Non-Member Prices

90.00

This interactive virtual discussion will advance your understanding of depression across the life span through clinical and research perspectives. Learn from two individual presentations, a panel of experts, and participate in live Q&As.

Learning Objectives:

  • Participants will be able to identify several examples of evidence-based biological and psychosocial treatments for depression.
  • Participants will be familiar with the role that individual and community factors play in the development and maintenance of depression.
  • Participants will be able to identify unique factors that play a role in the development and treatment of depression in youth and older adults.

Pricing:

  • ADAA Members: $60
  • ADAA Non-Members: $90
  • Students and Developing Country Professionals: $25
  • Journalists and Media Specialists: Free to Attend

Individual Presentations:

The Pros and Cons in Pushing the Antidepressant Drug Development Envelope (11:00 am - 12:00 pm ET)
featuring Alan F. Schatzberg, MD

In the past few years, the field has turned to agents with unique mechanisms of action that can be developed for patients particularly with refractory major depression or post-traumatic stress disorder.  Several of these are mind altering or potentially abuseable and the risk-benefit of these approaches needs to be discussed.  Dr. Schatzberg will present on the rationale for developing several of these agents and the potential problems for abuse or mind alteration that they may pose.  

When Discrimination Hurts: Depression in Minoritized Youth (12:00 pm - 1:00 pm ET)
featuring Gabriela Livas Stein, PhD

Dr. Stein will present research focusing on the impact of discrimination on Latinx and other minoritized youth and families, and how different culturally promotive and coping resources may be enacted by youth when experiencing discrimination. She will conclude by presenting on a new prevention program aimed at helping parents provide racial/ethnic socialization messages for youth of color called “One Talk at A Time.” 

Panel Discussion:

Innovations in Transdisciplinary Treatment for Depression Across the Lifespan (1:00 pm - 2:00 pm ET)
featuring Namkee Choi, PhD, Shawn Jones, PhD, MHS, Gabrielle Liverant, PhD, and David Mischoulon, MD, PhD

This panel discussion will take a transdisciplinary perspective on depression, featuring experts in the etiology and treatment of depression across the lifespan. Panelists bring expertise in depression in youth, families, and older adults; transdiagnostic and racial-ethnic, cultural, and identity factors underlying risk for depression; and in community-based, psychosocial, biological, and complementary and alternative medicine approaches to the treatment of depression. Moderated Gabrielle Liverant, PhD, the panel discussion will explore innovative approaches to understanding, preventing, and treating depression.

Should you not be able to participate live in all three hours of this Fall Forum Virtual Event, it will be recorded and available to registrants within 24 hours of the live event.  (To qualify for CE/CME credit, participants may be required to answer evaluation questions about each presentation.)

ADAA's 2021 Virtual Fall Forum is coordinated by the ADAA Professional Education Committee. A special thank you to Committee Chair Gabrielle Liverant, PhD.


Accreditation Statement

A picture containing drawing

Description automatically generatedIn support of improving patient care, this activity has been planned and implemented by Amedco LLC and Anxiety and Depression Association of America (ADAA).  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME)
Amedco LLC designates this live activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
Amedco LLC designates this enduring material for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
Psychologists (APA)
Amedco LLC designates this activity for a maximum of 3.0 Live Activity / 3.0 Enduring Material Psychologist contact hours. 
The following state boards accept courses from APA providers for Counselors: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, MD, ME, MO, NC, ND, NH, NE, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY
MI: No CE requirements
The following state boards accept courses from APA providers for MFTs: AK, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IN, KS, MD, ME, MO, NE, NC, NH, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY
MI: No CE requirement
The following state boards accept courses from APA providers for Addictions Professionals: AK, AR, CO, CT, DC, DE, GA, IA, IN, KS, LA, MD, MO, MT, NC, ND, NE, NJ, NM, NY (outstate held)*, OK, OR, SC, UT, WA, WI, WY
MA / MFTs: Participants can self-submit courses not approved by the MAMFT board for review.
The following state boards accept courses from APA providers for Social Workers: AK, AR, AZ, CA, CO, DE, FL, GA, ID, IN, KY, ME, MN, MO, NE, NH, NM, OR, PA, VT, WI, WY
* If the activity is held live in the state of NY, then direct addictions board is required, ie: NAADAC. If the activity is held outside NY, is virtual, enduring or remote, it is considered "outstate" and this reciprocity applies.
Social Workers (ASWB)
As a Jointly Accredited Organization, Amedco is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Amedco maintains responsibility for this course. Social Workers completing this course receive up to 3.0 Live Activity / 3.0 Enduring Material GENERAL continuing education credits.
The following state boards accept courses offering ASWB ACE credit for Social Workers: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NC, ND, NE,  NH, NM, NV, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WI, WV, WY
* WV accepts ASWB ACE unless activity is live in West Virginia, then an application is required.
The following state boards accept courses offering ASWB ACE credit for Counselors: AK, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, MA, MD, ME, MO, ND, NE, NM, NH, NV, OK, OR, PA, TN, TX, UT, VA, WI, WY
AL/Counselors: Activities not providing NBCC approval may be approved by the Board for individual licensees upon receipt of acceptable documentation prior to the activity.  Please send course details to your licensing board for approval BEFORE the event.  No approvals afterward by the board.
MI: No CE requirement
The following state boards accept courses offering ASWB ACE credit for MFTs: AK, AR, AZ, CA, CO, FL, IA, ID, IN, KS, MD, ME, MO, NC, NE, NH, NM, NV, OK, OR, PA, RI, TN, TX, UT, VA, WI, WY
MA / MFTs: Participants can self-submit courses not approved by the MAMFT board for review.
MI: No CE requirement
The following state boards accept courses offering ASWB ACE credit for Addictions Professionals: AK, CA, CO, CT, GA, IA, IN, KS, LA, MO, MT, ND, NM, NV, OK, OR, SC, WA, WI, WV, WY
New York Board for Social Workers (NY SW)
Amedco SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0115.
3.0 Live Activity / 3.0 Enduring Material.
New York Board for Psychology (NY PSY)
Amedco is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0031.
3.0 Live Activity / 3.0 Enduring Material.
NBCC
The Anxiety and Depression Association of American (ADAA) has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6872. Programs that do not qualify for NBCC credit are clearly identified. ADAA is solely responsible for all aspects of the programs.
CAMFT
The CAMFT board accepts credits from providers approved by the American Psychological Association (APA).

Presenter(s) Biography

Alan F. Schatzberg, MD

Alan F. Schatzberg, MD

Alan F. Schatzberg, MD
Kenneth T. Norris, Jr., Professor
Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
 

Alan F. Schatzberg received his M.D. from New York University in 1968.  He did his psychiatric residency at the Massachusetts Mental Health Center from 1969-1972 and was Chief Resident, Southard Clinic in 1971-1972. 

After serving in the United States Air Force, he joined the staff at McLean Hospital and the faculty of Harvard Medical School in 1974.  At McLean Hospital, he held a number of important positions including Service Chief, Interim Psychiatrist in Chief, Co-Director of the Affective Disorders Program (with Dr. J. Cole) and Director of the Depression Research Facility.  In 1988, he became Clinical Director of the Massachusetts Mental Health Center and Professor of Psychiatry at Harvard Medical School.  In 1991, Dr. Schatzberg moved to Stanford University to become the Kenneth T. Norris, Jr., Professor and Chairman of the Department of Psychiatry and Behavioral Sciences.  He served as Chair of the Department there until 2010 and directs the Stanford Mood Disorders Center.

Dr. Schatzberg has been an active investigator in the biology and psychopharmacology of depressive disorders.  He has authored over 700 publications and abstracts, including Schatzberg’s Manual of Clinical Psychopharmacology, whose ninth edition appeared in 2019 and which is co-authored by Dr. Charles DeBattista.  He also co-edited with Dr. Charles B. Nemeroff the Textbook of Psychopharmacology whose fifth edition appeared in 2017.  He was Co-Editor-in-Chief of the Journal of Psychiatric Research and sits on many other editorial boards as well, including Journal of Clinical Psychopharmacology, Psychoneuroendocrinology, Biological Psychiatry, and others.  He is a Past President of the American Psychiatric Association, American College of Neuropsychopharmacology (ACNP) and the Society of Biological Psychiatry and was also the Secretary-General of the International Society of Psychoneuroendocrinology.  He has received numerous awards, including; the 1998 Gerald L. Klerman, MD Lifetime Research Award from the NDMDA, the 2001 Gerald L. Klerman, MD Award from Cornell University Medical College, the 2001 Edward A. Strecker, MD Award from the University of Pennsylvania, the 2002 Mood Disorders Research Award from the American College of Psychiatrists, the 2002 American Psychiatric Association Award for Research, the 2005 Distinguished Service in Psychiatry Award from the American College of Psychiatrists, the 2005 Falcone Award from NARSAD, the 2013 Anna Monika Award, the 2014 Kraepelin Gold Medal from the Max Planck Institute of Psychiatry, the 2015 Gold Medal from the Society of Biological Psychiatry, the 2015 Lifetime Achievement Award of the ISPNE, 2017 Julius Axelrod Mentorship Award from the ACNP, etc.  In 2003, he was elected into the Institute of Medicine of the National Academy of Sciences (National Academy of Medicine).  He has received three honorary doctorate degrees.  
 

and

Gabriela Livas Stein, PhD

Gabriela Livas Stein, PhD

Gabriela Livas Stein, Ph.D., is a licensed psychologist and Professor of Clinical Psychology at the University of North Carolina at Greensboro. Dr. Stein’s program of research identifies individual risk and protective processes for Latinx and other minoritized youth when facing cultural stressors (e.g., discrimination, acculturative stress), and seeks to improve mental health treatment access for Latinx families. Broadly, her research investigates the impact of culturally resilience factors like familism and coping on the development of psychopathology and well-being for minoritized samples. She has published more than 60 peer reviewed papers on these topics. Her research has been funded by NIDA, NIMH, and PCORI. She is currently the Vice President of Programming for the Society of Research on Adolescence. Clinically, she specializes in the provision of therapeutic services to Latinx families, and provides training to providers working with Latinx communities. 

and

Namkee Choi, PhD

Namkee Choi, PhD

Namkee Choi, PhD, is Professor and Louis and Ann Wolens Centennial Chair in Gerontology in the University of Texas at Austin Steve Hicks School of Social Work. She received her MSW degree from the University of Minnesota, PhD from the University of California at Berkeley, and intensive geriatric mental health research training at the Advanced Research Institute in Geriatric Mental Health.  

Dr. Choi’s primary research/practice goal is to improve low-income, especially racial/ethnic minority, older adults’ access to mental health services. To realize this goal, Dr. Choi leads a team that has conducted randomized clinical trials (RCTs) of effectiveness of videoconferenced depression treatments and prevention (via improving social connectedness and reducing social isolation) for homebound older adults. Her community partners include Meals on Wheels, Area Agencies on Aging, and other aging service network agencies. She received funding from the NIH, AARP Foundation (national), and St. David’s Foundation. Dr. Choi has also done extensive research on late-life suicide and substance misuse among older adults.  She is the 2021 recipient of the Gerontological Society of America’s Maxwell A. Pollack Award for Contributions to Healthy Aging. 

and

Shawn Jones, PhD, MHS

Dr. Shawn Jones

Dr. Shawn Jones is an Assistant Professor in the Counseling Program in the Psychology Department at Virginia Commonwealth University. He received his doctorate in Clinical Psychology with an emphasis on Children and Families from the University of North Carolina at Chapel Hill and was a Child Clinical Psychology Predoctoral intern at UCLA. Dr. Jones endeavors to impact the psychosocial wellbeing of Black youth and their families by: a) exploring mechanisms undergirding culturally-relevant protective and promotive factors; b) translating basic research into interventions that harness the unique strengths of the Black experience; and c) disseminating this research to be consumed, critiqued and enhanced by the communities the work intends to serve.

and

Gabrielle Liverant, PhD

Gabrielle Liverant, PhD

Gabrielle Liverant, PhD is a clinical psychologist and Associate Professor of Psychology at Suffolk University. Dr. Liverant's research centers on the identification of shared etiological mechanisms that underlie mood, anxiety, and trauma and stressor related disorders, and the translation of this knowledge into more effective psychotherapeutic and pharmacological interventions. Her recent work has focused on enhancing understanding of anhedonia, associated reward system impairments, and emotional reactivity and regulation dysfunction across psychiatric disorders. The transdiagnostic, phenotypic focus of Dr. Liverant's research is designed to promote the dissemination and application of new interventions across disorders and populations (e.g., depression, PTSD).

and

David Mischoulon, MD, PhD

David Mischoulon, MD, PhD

Dr. Mischoulon is the Joyce Root Tedlow Professor of Psychiatry at Harvard Medical School, and Director of the Depression Clinical and Research Program (DCRP) at MGH. He graduated in 1994 from the MD-PhD program at Boston University School of Medicine, and completed his residency in adult psychiatry at MGH in 1998, serving as Chief Resident in Pscyhopharmacology.

Dr. Mischoulon's research has focused on various areas of depression, including psychopharmacology and complementary and alternative medicine. His research on omega-3 fatty acids has been funded my NARSAD, MCCAM/NCCIH, and the NIH. He mentors researchers from all over the world. He has published more than 300 articles, a textbook on natural medications, and a guide to treatments of depression. He has been an invited speaker at various sites around the country and internationally, and is a Distinguished Fellow of the American Psychiatric Association.

In addition to his research activities, Dr. Mischoulon teaches and supervises MGH/McLean psychiatry residents and Harvard medical students, and also lectures in various MGH/Harvard continuing medical education programs. He serves as Director of Training in the MGH Clinical Trials Network and Institute (CTNI), where he educates research clinicians on the proper administrative of diagnostic instruments in clinical trials. He also cares for patients through the DCRP clinical practice, and is regularly sought out for consultation regarding management of treatment-resistant depression and use of complementary therapies for psychiatric disorders.

and
Professional Post
On
CE/CME Accreditation Statement

ADAA Continuing Education Credits for Live and On-Demand Programming

Learners complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available.  If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Some ADAA professional webinars focused on diversity or cultural competency subject matter are eligible for the Cross-Culture Competency Diversity Credit. If a webinar is eligible for this credit, it will be reflected on your credit certificate.

All continuing education credits are provided through Amedco, LLC. Learn more about the CE/CME accreditation information here.